These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5805234)

  • 1. Studies with orally administered H3 palmitate in two types of hyperlipoproteinemia.
    Brown DF; Balint JA
    Am J Med Sci; 1969 Aug; 258(2):121-33. PubMed ID: 5805234
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antilipemic agents and postprandial lipidemia].
    Shepherd J; Simpson H; Williamson CM; Pringle S; MacLean J; Lorimer AR; Packard CJ
    Klin Wochenschr; 1990; 68 Suppl 22():83-8. PubMed ID: 2087086
    [No Abstract]   [Full Text] [Related]  

  • 3. Splanchnic secretion rates of plasma triglycerides and total and splanchnic turnover of plasma free fatty acids in men with normo- and hypertriglyceridaemia.
    Boberg J; Carlson LA; Freyschuss U; Lassers BW; Wahlqvist ML
    Eur J Clin Invest; 1972 Nov; 2(6):454-66. PubMed ID: 4655971
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the influence of a fat-modified diet in healthy subjects and in patients with hyperlipoproteinemia].
    Matzkies F; Berg G; Grabner W; Bergner D
    Fortschr Med; 1974 Nov; 92(31):1257-60. PubMed ID: 4373357
    [No Abstract]   [Full Text] [Related]  

  • 5. Xanthomatosis and hyperlipoproteinemia; a review.
    Polano MK
    Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
    [No Abstract]   [Full Text] [Related]  

  • 6. Type IV hyperlipoproteinemia. A critical appraisal.
    Schonfeld G; Kudzma DJ
    Arch Intern Med; 1973 Jul; 132(1):55-62. PubMed ID: 4716427
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of serum triglyceride levels by polyunsaturated fat. Studies on the mode of action and on very low density lipoprotein composition.
    Chait A; Onitiri A; Nicoll A; Rabaya E; Davies J; Lewis B
    Atherosclerosis; 1974; 20(2):347-64. PubMed ID: 4370323
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of hyperlipoproteinemia.
    Havel RJ
    Adv Exp Med Biol; 1972; 26(0):57-70. PubMed ID: 4370189
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.
    Brunzell JD; Hazzard WR; Porte D; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1578-85. PubMed ID: 4352459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hyperchylomicronemia. Enzymatic and physiologic studies.
    Ford S; Schubert WK; Glueck CJ; Bozian RC
    Am J Med; 1971 Apr; 50(4):536-41. PubMed ID: 5572597
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma triglyceride metabolism].
    Polonovski J
    C R Seances Soc Biol Fil; 1975; 169(5):1129-44. PubMed ID: 178412
    [No Abstract]   [Full Text] [Related]  

  • 12. Efcts of chronic ethanol feeding on serum lipoprotein metabolism in the rat.
    Baraona E; Lieber CS
    J Clin Invest; 1970 Apr; 49(4):769-78. PubMed ID: 5443177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of hyperlipidemia.
    Lees RS; Wilson DE
    N Engl J Med; 1971 Jan; 284(4):186-95. PubMed ID: 4923684
    [No Abstract]   [Full Text] [Related]  

  • 14. [Xanthomatosis eruptiva papulosa (hyperlipoproteinemia type V)].
    Vigh C; Czinder K; Mátyus L
    Z Hautkr; 1974 Oct; 49(19):819-28. PubMed ID: 4464725
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional overlap between "chylomicra" and "very low density lipoproteins" of human plasma during alimentary lipaemia.
    Chait A; Lewis B; February AW; Mattock M
    Atherosclerosis; 1973; 17(3):455-62. PubMed ID: 4351721
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperlipoproteinemia and pancreatitis.
    Farmer RG; Winkelman EI; Brown HB; Lewis LA
    Am J Med; 1973 Feb; 54(2):161-5. PubMed ID: 4685843
    [No Abstract]   [Full Text] [Related]  

  • 17. Dietary management of hyperlipoproteinemia.
    Levy RI; Bonnell M; Ernst ND
    J Am Diet Assoc; 1971 May; 58(5):406-16. PubMed ID: 5574141
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inhibition of metabolism of triglyceride-rich lipoproteins by postheparin lipolytic activity in hyperlipoproteinemia type III].
    Augustin J; Geursen R; Wieland H; Klose G; Greten H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():387-9. PubMed ID: 206056
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of dietary triacylglycerol structure on lipoprotein metabolism: a comparison of the effects of dioleoylpalmitoylglycerol in which palmitate is esterified to the 2- or 1(3)-position of the glycerol.
    Pufal DA; Quinlan PT; Salter AM
    Biochim Biophys Acta; 1995 Aug; 1258(1):41-8. PubMed ID: 7654779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dietary modification of the postprandial phase].
    Canzler H
    Klin Wochenschr; 1990; 68 Suppl 22():76-82. PubMed ID: 2087085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.